Patients with severe arthritis are to be given access to a new generation of drug on the NHS, advisers have ruled. The National Institute for Health and Clinical Excellence (NICE) has approved the so-called “smart drug” MabThera.
Patients with severe arthritis are to be given access to a new generation of drug on the NHS, advisers have ruled. The National Institute for Health and Clinical Excellence (NICE) has approved the so-called “smart drug” MabThera.
